TOP TIERMARKET NEWSWIRE
News & sentiment

CONTINEUM THERAPEUTI A (CTNM) — News & AI sentiment

CONTINEUM THERAPEUTI A (CTNM) news roundup. 1 story in the last 24 hours, 2 in the past week, 12 over 30 days. Average 24-hour sentiment is 53/100 — neutral (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 2 sales totalling $81K — net selling of $81K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 53/100
7d stories
2
avg sentiment 55.5/100
30d stories
12
avg sentiment 56.3/100
Insider net (90d)
$81K
0 buys · 2 sells
Congress (90d)
0
0 buys · 0 sells

CTNM news in the last 24 hours, 7 days, 30 days and 90 days

How much CTNM coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowCTNM storiesAvg AI sentimentRead
Last 24 hours153/100CTNM headlines →
Last 7 days255.5/100CTNM headlines →
Last 30 days1256.3/100CTNM headlines →
Last 90 days3348.8/100CTNM headlines →

Latest stories on CTNM

8h ago
2d ago
Oct 15
Oct 14
Baird downgrades Contineum Therapeutics stock on IPF trial data
Investing.com Analyst Ratings31 · bearishanalyst
Oct 13
Oct 13
Oct 12
Oct 12
Why is Contineum Therapeutics stock surging today?
Investing.com Markets72 · bullishgeneral
Oct 12
Contineum Therapeutics stock surges on Bristol Myers trial win
Investing.com Markets74 · bullishproduct/pr
Oct 12
Sep 30
Stifel reiterates Contineum Therapeutics stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Sep 30
Sep 29
Sep 29
Sep 27
Sep 24
Goldman Sachs initiates coverage on Contineum Therapeutics stock
Investing.com Analyst Ratings56 · neutralanalyst
Sep 24
Sep 24
Sep 15
Stifel maintains Buy on Contineum stock after phase 2 trial miss
Investing.com Analyst Ratings56 · neutralanalyst
Sep 15
Sep 15
Sep 15
Sep 14
Sep 14
Sep 14
Open CTNM in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →